<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) biopsies and cell lines carry a c-myc/Ig translocation </plain></SENT>
<SENT sid="1" pm="."><plain>The resulting constitutive activation of c-myc is regarded as an essential factor for the progressive growth of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>At least 60% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines carry a mutated p53 gene as well </plain></SENT>
<SENT sid="3" pm="."><plain>It has been shown that the growth of mutant p53 carrying <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells could be inhibited by the introduction of <z:mp ids='MP_0002169'>wild-type</z:mp> p53 </plain></SENT>
<SENT sid="4" pm="."><plain>In order to examine whether this also applies to the presumably 'myc-driven' <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell, we have transfected the Epstein-Barr virus (EBV) negative BL41 cell line with a temperature sensitive p53 mutant (p53-Val135) that expresses p53 with a largely mutant conformation at 37.5 degrees C and mostly <z:mp ids='MP_0002169'>wild-type</z:mp> conformation at 32 degrees C </plain></SENT>
<SENT sid="5" pm="."><plain>At 37.5 degrees C, the p53-Val135 transfected cells behaved like the parental or neo transfected control cells </plain></SENT>
<SENT sid="6" pm="."><plain>However, expression of exogenous <z:mp ids='MP_0002169'>wild-type</z:mp> p53 at 32 degrees C resulted in a rapid reduction of the number of viable cells while the parental and neo control cells remained unaffected </plain></SENT>
<SENT sid="7" pm="."><plain>Cell <z:hpo ids='HP_0011420'>death</z:hpo> was due to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> as shown by chromatin and nuclear condensation and specific DNA fragmentation </plain></SENT>
<SENT sid="8" pm="."><plain>The first signs of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> were evident after 10 h at 32 degrees C and after 3 days 90-100% of the cells had undergone <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>These findings indicate an incompatibility between expression of <z:mp ids='MP_0002169'>wild-type</z:mp> p53 and progressive growth of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells if their neoplastic development has included a p53 mutation </plain></SENT>
<SENT sid="10" pm="."><plain>The question whether <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was induced in by the <z:mp ids='MP_0002169'>wild-type</z:mp> protein per se or by the contradictory signals of a constitutively activated c-myc and <z:mp ids='MP_0002169'>wild-type</z:mp> p53 needs further investigation </plain></SENT>
</text></document>